results

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

January 26, 2026 17:00 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

4 months ago

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

January 23, 2026 17:25 ET  | Source: Immunovant Inc. DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) --…

4 months ago

STL reports Q3 FY’26 results; strengthens technology leadership

MUMBAI, India, Jan. 23, 2026 /PRNewswire/ -- STL (NSE: STLTECH), a leading connectivity solutions provider for AI-ready digital infrastructure, today…

4 months ago

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

January 22, 2026 16:05 ET  | Source: Adaptive Biotechnologies SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:…

4 months ago

Canara HSBC Life Insurance Delivers Robust 9M FY26 Results

PERFORMANCE FOR THE QUARTER ENDED DECEMBER 31, 2025Individual weighted premium income of ₹ 1,915.3 crore with a year-on-year growth of…

4 months ago

Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System

Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right…

4 months ago

Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in premier…

4 months ago

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…

4 months ago

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am ET / 5:00 am PT…

4 months ago

Bank of America Reports Fourth Quarter 2025 Financial Results

CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- Bank of America reported its fourth quarter 2025 financial results today. The news…

4 months ago